AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRIESS ASSOCIATES LLC | 97,760 | $3,401,000 | 5.68% |
| Nantahala Capital Management | 1,000,000 | $34,790,000 | 1.74% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 341,294 | $11,874,000 | 1.52% |
| Portolan Capital Management | 274,889 | $9,563,000 | 0.96% |
| Quantedge Capital Pte Ltd | 121,500 | $4,227,000 | 0.85% |
| SHAKER INVESTMENTS LLC/OH | 37,117 | $1,291,000 | 0.82% |
| GLOBEFLEX CAPITAL L P | 72,253 | $2,514,000 | 0.61% |
| EAM Investors, LLC | 68,855 | $2,395,000 | 0.58% |
| Hillsdale Investment Management Inc. | 197,738 | $6,879,000 | 0.55% |
| Capital Impact Advisors, LLC | 13,835 | $481,000 | 0.44% |